<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629252</url>
  </required_header>
  <id_info>
    <org_study_id>98_PPI-P50</org_study_id>
    <secondary_id>E-11/2007</secondary_id>
    <secondary_id>2007DR1253</secondary_id>
    <nct_id>NCT00629252</nct_id>
  </id_info>
  <brief_title>The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>H. Lundbeck A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate whether the atypical antipsychotic and mixed 5-HT2/D2
      antagonist sertindole modulates or improves both subcortical and cortical information
      processing in schizophrenic patients who had not or insufficiently responded to previous
      antipsychotic medication. This goal shall be accomplished by investigating the effect of
      sertindole of both prepulse inhibition of the acoustic startle (PPI) and P50 suppression of
      auditory evoked potentials in schizophrenic patients. These effects shall be compared to the
      effect of risperidone and shall also be compared to untreated healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not enough subjects have been recruited in the expected period.
  </why_stopped>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sensory (EEG: P50 suppression) and sensorimotor gating (EMG: PPI)</measure>
    <time_frame>Before and six weeks after antipsychotic treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive performances</measure>
    <time_frame>Before and six weeks after antipsychotic treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychopathology (PANSS rating)</measure>
    <time_frame>Before and six weeks after antipsychotic treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Schizophrenic patients treated with sertindole</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Schizophrenic patients treated with risperidone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy controls without any treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertindole</intervention_name>
    <description>oral 12-20 mg/day</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
    <description>oral 2-6mg / day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Schizophrenia according to DSM IV

          -  Selected and treated in respect of the SPC (20 mg Serdolect max. and population at
             risk will be excluded)

        Exclusion Criteria:

          -  DSM IV Axis I disorders other than schizophrenia: Substance-dependence (excepting
             nicotine-dependence and substance-abuse), recent (2 months) DSM IV diagnosis according
             to DIA-X of a major affective, anxiety disorder, eating-disorder.

          -  DSM IV Axis II disorders: Lifetime DSM IV diagnosis of personality disorder.

          -  ECG: QTc-interval &gt;450 msec.

          -  Systolic blood pressure &lt;100 mmHg

          -  Bradycardia (Hf &lt; 50/Min) und Arrhythmias

          -  Hypokalemia or Hypomagnesemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franz X. Vollenweider, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>CH-8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2008</study_first_submitted>
  <study_first_submitted_qc>February 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2008</study_first_posted>
  <last_update_submitted>September 14, 2012</last_update_submitted>
  <last_update_submitted_qc>September 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>PPI</keyword>
  <keyword>P50</keyword>
  <keyword>CANTAB</keyword>
  <keyword>sensory gating</keyword>
  <keyword>Schizophrenic patients according to DSM-IV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Sertindole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

